{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:06:35Z","timestamp":1775754395409,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,19]]},"DOI":"10.7759\/cureus.30460","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T10:37:46Z","timestamp":1666175866000},"source":"Crossref","is-referenced-by-count":1,"title":["The Prevalence of Atypical Antipsychotics, Antidepressants, and Benzodiazepines Use in Dementia Patients in King Abdulaziz Medical City"],"prefix":"10.7759","author":[{"given":"Amani J","family":"Basaeed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gada","family":"Wafia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashair","family":"Alhidri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla A","family":"Sindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alqassem","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisreen","family":"Jastaniah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Population aging in","author":"Abusaaq H","year":"2015","unstructured":"Abusaaq H. Population Aging in Saudi Arabia. Saudi Arabian Monetary Agency (SAMA), Jeddah; 2015. https:\/\/www.sama.gov.sa\/en-US\/EconomicResearch\/WorkingPapers\/population%20aging%20in%20saudi%20arabia.pdf."},{"key":"ref2","article-title":"Epidemiology of cognitive aging in the oldest old","volume":"68","author":"Giulioli C","year":"2016","unstructured":"Giulioli C, Amieva H. Epidemiology of cognitive aging in the oldest old. Rev Invest Clin. 2016, 68:33-9.","journal-title":"Rev Invest Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri CP","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, et al.. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005, 366:2112-7. 10.1016\/S0140-6736(05)67889-0","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study","volume":"23","author":"Steinberg M","year":"2008","unstructured":"Steinberg M, Shao H, Zandi P, et al.. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry. 2008, 23:170-7. 10.1002\/gps.1858","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.12030342","article-title":"Atypical antipsychotic use in patients with dementia: managing safety concerns","volume":"169","author":"Steinberg M","year":"2012","unstructured":"Steinberg M, Lyketsos CG. Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry. 2012, 169:900-6. 10.1176\/appi.ajp.2012.12030342","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.09.017","article-title":"Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?","volume":"59","author":"Trifir\u00f2 G","year":"2009","unstructured":"Trifir\u00f2 G, Spina E, Gambassi G. Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?. Pharmacol Res. 2009, 59:1-12. 10.1016\/j.phrs.2008.09.017","journal-title":"Pharmacol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519020-00001","article-title":"Do atypical antipsychotics cause stroke?","volume":"19","author":"Herrmann N","year":"2005","unstructured":"Herrmann N, Lanct\u00f4t KL. Do atypical antipsychotics cause stroke?. CNS Drugs. 2005, 19:91-103. 10.2165\/00023210-200519020-00001","journal-title":"CNS Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000230","article-title":"Continuity of treatment with benzodiazepines in dementia patients: an analysis of German health insurance claims data","volume":"33","author":"Hessmann P","year":"2018","unstructured":"Hessmann P, Jan Zeidler, Neubauer S, et al.. Continuity of treatment with benzodiazepines in dementia patients: an analysis of German health insurance claims data. Int Clin Psychopharmacol. 2018, 33:282-9. 10.1097\/YIC.0000000000000230","journal-title":"Int Clin Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0434-6","article-title":"Management of depression in patients with dementia: is pharmacological treatment justified?","volume":"34","author":"Ford AH","year":"2017","unstructured":"Ford AH, Almeida OP. Management of depression in patients with dementia: is pharmacological treatment justified?. Drugs Aging. 2017, 34:89-95. 10.1007\/s40266-016-0434-6","journal-title":"Drugs Aging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1533317510390351","article-title":"Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence","volume":"26","author":"Mittal V","year":"2011","unstructured":"Mittal V, Kurup L, Williamson D, Muralee S, Tampi RR. Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence. Am J Alzheimers Dis Other Demen. 2011, 26:10-28. 10.1177\/1533317510390351","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0538-x","article-title":"Antipsychotic prescribing to patients diagnosed with dementia without a diagnosis of psychosis in the context of national guidance and drug safety warnings: longitudinal study in UK general practice","volume":"40","author":"Stocks SJ","year":"2017","unstructured":"Stocks SJ, Kontopantelis E, Webb RT, Avery AJ, Burns A, Ashcroft DM. Antipsychotic prescribing to patients diagnosed with dementia without a diagnosis of psychosis in the context of national guidance and drug safety warnings: longitudinal study in UK general practice. Drug Saf. 2017, 40:679-92. 10.1007\/s40264-017-0538-x","journal-title":"Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000528","article-title":"Movement disorders in adults with intellectual disability and behavioral problems associated with use of antipsychotics","volume":"36","author":"Scheifes A","year":"2016","unstructured":"Scheifes A, Walraven S, Stolker JJ, Nijman HL, Tenback DE, Egberts TC, Heerdink ER. Movement disorders in adults with intellectual disability and behavioral problems associated with use of antipsychotics. J Clin Psychopharmacol. 2016, 36:308-13. 10.1097\/JCP.0000000000000528","journal-title":"J Clin Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146","author":"Gill SS","year":"2007","unstructured":"Gill SS, Bronskill SE, Normand SL, et al.. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007, 146:775-86. 10.7326\/0003-4819-146-11-200706050-00006","journal-title":"Ann Intern Med"},{"key":"ref14","unstructured":"European Medicines Agency evaluation of medicines for human use\r\n. (2008). Accessed. September 11, 2022: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/opinion-following-article-30-referral-risperdal-associated-names-inte...."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200926060-00005","article-title":"Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data","volume":"26","author":"Kamble P","year":"2009","unstructured":"Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009, 26:483-92. 10.2165\/00002512-200926060-00005","journal-title":"Drugs Aging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2014.07.012","article-title":"Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study","volume":"15","author":"Foebel AD","year":"2014","unstructured":"Foebel AD, Liperoti R, Onder G, et al.. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study. J Am Med Dir Assoc. 2014, 15:911-7. 10.1016\/j.jamda.2014.07.012","journal-title":"J Am Med Dir Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000181","article-title":"Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based study","volume":"32","author":"Chiu YW","year":"2017","unstructured":"Chiu YW, Huang CW, Chen PJ, Yu NW, Tsai HJ, Wu CS, Chang CM. Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based study. Int Clin Psychopharmacol. 2017, 32:262-70. 10.1097\/YIC.0000000000000181","journal-title":"Int Clin Psychopharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/2040622316658463","article-title":"Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses","volume":"7","author":"Tampi RR","year":"2016","unstructured":"Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis. 2016, 7:229-45. 10.1177\/2040622316658463","journal-title":"Ther Adv Chronic Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3527","article-title":"Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls","volume":"22","author":"Schulze J","year":"2013","unstructured":"Schulze J, Glaeske G, van den Bussche H, Kaduszkiewicz H, Koller D, Wiese B, Hoffmann F. Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf. 2013, 22:1308-16. 10.1002\/pds.3527","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"Maust DT","year":"2015","unstructured":"Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015, 72:438-45. 10.1001\/jamapsychiatry.2014.3018","journal-title":"JAMA Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1049-5","article-title":"Management of behavioral and psychological symptoms of dementia","volume":"21","author":"Bessey LJ","year":"2019","unstructured":"Bessey LJ, Walaszek A. Management of behavioral and psychological symptoms of dementia. Curr Psychiatry Rep. 2019, 21:66. 10.1007\/s11920-019-1049-5","journal-title":"Curr Psychiatry Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610214002427","article-title":"Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study","volume":"27","author":"Laitinen ML","year":"2015","unstructured":"Laitinen ML, L\u00f6nnroos E, Bell JS, Lavikainen P, Sulkava R, Hartikainen S. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study. Int Psychogeriatr. 2015, 27:669-72. 10.1017\/S1041610214002427","journal-title":"Int Psychogeriatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610209008497","article-title":"Sex differences in the prevalence of behavioral and psychological symptoms of dementia","volume":"21","author":"L\u00f6vheim H","year":"2009","unstructured":"L\u00f6vheim H, Sandman PO, Karlsson S, Gustafson Y. Sex differences in the prevalence of behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2009, 21:469-75. 10.1017\/S1041610209008497","journal-title":"Int Psychogeriatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115950-the-prevalence-of-atypical-antipsychotics-antidepressants-and-benzodiazepines-use-in-dementia-patients-in-king-abdulaziz-medical-city","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:47Z","timestamp":1707508307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115950-the-prevalence-of-atypical-antipsychotics-antidepressants-and-benzodiazepines-use-in-dementia-patients-in-king-abdulaziz-medical-city"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.30460","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,19]]}}}